EP Patent

EP4101454B1 — Compositions for use in the treatment of hypertension

Assigned to George Institute for Global Health · Expires 2024-04-10 · 2y expired

What this patent protects

Patent listed against Caduet.

Drugs covered by this patent

Caduet (Amlodipine Besylate) · Pfizer Inc.

Patent Metadata

Patent number: EP4101454B1
Jurisdiction: EP
Classification: —
Expires: 2024-04-10
Drug substance claim: No
Drug product claim: No
Assignee: George Institute for Global Health
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.